# Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction

> **NCT01595113** · — · COMPLETED · sponsor: **Pharmicell Co., Ltd.** · enrollment: 41 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01595113
- **Lead sponsor:** Pharmicell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595113, "Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01595113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*